Beijing Life Capital Management Co., Ltd. signed the share transfer agreement to acquire a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHSE:600381) from Tibet Rongen Technology Co., Ltd. for approximately CNY 200 million on December 10, 2021. Beijing Life Capital Management will acquire 29,353,200 shares of Qinghai Spring Medicinal Resources Technology Co., Ltd. at a price of CNY 6.7 per share. Post transaction, Tibet Rongen Technology Co., Ltd. will retain 199,115,194 shares representing 33.92% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd.
Qinghai Spring Medicinal Resources Technology Co., Ltd.
Equities
600381
CNE0000017W0
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.29 CNY | -1.29% | +17.44% | -70.38% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-70.38% | 187M | |
+27.19% | 5.36B | |
-33.59% | 3.4B | |
-2.97% | 2.9B | |
-24.21% | 2.53B | |
-10.11% | 2.27B | |
+43.66% | 1.84B | |
+46.15% | 1.42B | |
+41.90% | 1.38B | |
-13.92% | 1.37B |
- Stock Market
- Equities
- 600381 Stock
- News Qinghai Spring Medicinal Resources Technology Co., Ltd.
- Beijing Life Capital Management Co., Ltd. signed the share transfer agreement to acquire a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. from Tibet Rongen Technology Co., Ltd. for approximately CNY 200 million.